MATURA - Highlights and News

MAximising Therapeutic Utility in Rheumatoid Arthritis

Highlights and News

Biotech Merger Tests AI Patient Stratification Against RA's 70% Treatment Gap - Tech Times: Biotech Merger Tests AI Patient Stratification Against RA's 70% Treatment Gap Tech Times
Deep molecular profiling of synovial biopsies in the STRAP trial identifies signatures predictive of treatment response to biologic therapies in rheumatoid arthritis - Nature: Deep molecular profiling of synovial biopsies in the STRAP trial identifies signatures predictive of treatment response to biologic therapies in rheumatoid arthritis Nature
Is There a Missing Link in Rheumatoid Arthritis Management? - emjreviews.com: Is There a Missing Link in Rheumatoid Arthritis Management? emjreviews.com
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial - Nature: Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial Nature
A longitudinal cohort study uncovers plasma protein biomarkers predating clinical onset and treatment response of rheumatoid arthritis - Nature: A longitudinal cohort study uncovers plasma protein biomarkers predating clinical onset and treatment response of rheumatoid arthritis Nature
Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue - Nature: Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue Nature
Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics | Scientific Reports - Nature: Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics | Scientific Reports Nature

The MATURA consortium includes academic groups and industry partners working together to identify and test biomarkers
predictive of response to biological therapy in patients with rheumatoid arthritis

Highlights and News

Related